| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/12/2013 | US8372381 Achieving long-term release of health enhancing elements from chemical components |
| 02/12/2013 | US8372040 Portable drug delivery device including a detachable and replaceable administration or dosing element |
| 02/12/2013 | US8371296 Method and apparatus for nitric oxide generation |
| 02/12/2013 | US8371292 Use of ciclesonide for the treatment of respiratory diseases |
| 02/12/2013 | CA2694238C Pharmaceutical aerosol compositions comprising fluticasone |
| 02/12/2013 | CA2648313C Calcium phosphate complex in acid containing chewing gum |
| 02/12/2013 | CA2601222C Once-a-day oxycodone formulations |
| 02/12/2013 | CA2587392C Solid particles from controlled destabilisation of microemulsions |
| 02/12/2013 | CA2580577C Amitraz compositions |
| 02/12/2013 | CA2579711C Controlled release delivery system for bio-active agents |
| 02/12/2013 | CA2574623C Acidic solid oral compositions without erosive potential in saliva and method for determining erosive potential in saliva |
| 02/12/2013 | CA2567827C Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons |
| 02/12/2013 | CA2549539C Taste masked pharmaceutical composition comprising ph sensitive polymer |
| 02/12/2013 | CA2548249C Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product |
| 02/12/2013 | CA2535013C Micro-particle fatty acid salt solid dosage formulations for therapeutic agents |
| 02/12/2013 | CA2526933C Composition for maintaining organ and cell viability |
| 02/12/2013 | CA2510813C Injectable pharmaceutical compositions comprising sodium diclofenac and .beta.-cyclodextrin |
| 02/12/2013 | CA2492747C Medicaments containing vardenafil hydrochloride trihydrate |
| 02/12/2013 | CA2492089C Delivery system for pharmaceutical agents |
| 02/12/2013 | CA2477350C Novel crystalline forms of the anti-cancer compound zd1839 |
| 02/12/2013 | CA2475310C Antimicrobial streptococcus salivarius strain and use thereof for preventing dental caries |
| 02/12/2013 | CA2461740C Synthesis of cyclosporin analogs |
| 02/12/2013 | CA2366880C Compositions of polyacids and polyethers and methods for their use in reducing adhesions |
| 02/12/2013 | CA2359650C Pharmaceutical preparations and methods for inhibiting tumors |
| 02/11/2013 | DE202013100008U1 Mikrokapsel mit einer Nanometallflüssigkeit Microcapsule having a nano liquid metal |
| 02/11/2013 | DE202006021148U1 Stabile, haltbare Granulate mit aktiven Mitteln Sturdy, durable granules with active agents |
| 02/10/2013 | CA2784853A1 Solid pharmaceutical compound for oral administration of agomelatine |
| 02/07/2013 | WO2013020136A2 Treatment of traumatic brain injury |
| 02/07/2013 | WO2013020094A2 Novel hemostatic patch and uses thereof |
| 02/07/2013 | WO2013020040A2 Radiated cancer cells as a vehicle for cancer nanotherapy |
| 02/07/2013 | WO2013020021A1 Stable anti-inflammatory solutions for injection |
| 02/07/2013 | WO2013019891A1 Non-digestible capsules for the delivery of fluid absorbing materials |
| 02/07/2013 | WO2013019872A1 Process for preparing pharmaceutical compositions comprising fingolimod |
| 02/07/2013 | WO2013019733A2 Methods, compositions and kits for therapeutic treatment with wet spun microstructures |
| 02/07/2013 | WO2013019669A2 Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses |
| 02/07/2013 | WO2013019658A2 Synthetic nanocarriers comprising polymers comprising multiple immunomodulatory agents |
| 02/07/2013 | WO2013019648A1 Control of antibody responses to synthetic nanocarriers |
| 02/07/2013 | WO2013019372A2 Thermally-conductive, metal-based bandages to aid in medical healing and methods of use |
| 02/07/2013 | WO2013019222A1 Compositions and methods for treating myelodysplastic syndrome |
| 02/07/2013 | WO2013019221A1 Compositions and methods for treating myelodysplastic syndrome |
| 02/07/2013 | WO2013019220A1 Compositions and methods for treating myelodysplastic syndrome |
| 02/07/2013 | WO2013019137A1 Oxide ferrimagnetics with spinel structure nanoparticles and iron oxide nanoparticles, biocompatible aqueous colloidal systems comprising nanoparticles, ferriliposomes, and uses thereof |
| 02/07/2013 | WO2013019090A1 Hydrophilic nanoparticles surface-modified with monosaccharide phosphate or monosaccharide phosphate derivatives, its colloidal solution and use thereof |
| 02/07/2013 | WO2013019056A1 Novel granule formulation containing sildenafil or pharmaceutically acceptable salts thereof as an active ingredient |
| 02/07/2013 | WO2013019049A1 Complex comprising steviol glycosides orlicorice root, and poorly soluble material |
| 02/07/2013 | WO2013019024A1 Preparation for oral administration with improved bioavailability of megestrol acetate, and method for improving bioavailability of megestrol acetate preparation for oral administration |
| 02/07/2013 | WO2013018766A1 Stable pharmaceutical composition |
| 02/07/2013 | WO2013018765A1 Pharmaceutical composition containing loxoprofen |
| 02/07/2013 | WO2013018091A1 Particles for the treatment of neurodegenerative diseases |
| 02/07/2013 | WO2013018050A2 Dissolution enhanced controlled drug delivery system for poorly water soluble drugs |
| 02/07/2013 | WO2013018035A1 Pharmaceutical composition comprising factor vii encapsulated in micelles |
| 02/07/2013 | WO2013018031A1 Pharmaceutical compositions for gastrointestinal drug delivery |
| 02/07/2013 | WO2013018018A1 Antitumour combination comprising ombrabulin and cetuximab, associated with radiotherapy |
| 02/07/2013 | WO2013018017A1 Antitumour combination comprising ombrabulin and cisplatin, associated with radiotherapy |
| 02/07/2013 | WO2013018008A1 Basic alpha lipoic acid solution and its uses |
| 02/07/2013 | WO2013017977A1 Compositions and methods for the treatment of cancer |
| 02/07/2013 | WO2013017928A1 Pharmaceutical compositions comprising rifaximin, processes for their preparation and their use in the treatment of vaginal infections |
| 02/07/2013 | WO2013017910A1 Extended release pharmaceutical compositions containing paliperidone |
| 02/07/2013 | WO2013017821A1 Pharmaceutical composition comprising ebastine and fluticasone |
| 02/07/2013 | WO2013017808A1 Antiseptic composition |
| 02/07/2013 | WO2013017807A1 Antiseptic composition |
| 02/07/2013 | WO2013017689A1 Application aid |
| 02/07/2013 | WO2013017686A1 Protective-film changer |
| 02/07/2013 | WO2013017571A1 Aqueous solutions of lipophilic substances, in particular medicinal solutions |
| 02/07/2013 | WO2013017494A1 Pharmaceutical composition of oxidised avidin suitable for inhalation |
| 02/07/2013 | WO2013017242A1 Tamper-resistant tablet providing immediate drug release |
| 02/07/2013 | WO2013017234A1 Tamper-resistant tablet providing immediate drug release |
| 02/07/2013 | WO2013017233A1 Intrathecal or epidural administration of 3-[(1s,2s)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol |
| 02/07/2013 | WO2013017100A1 Imatinib mesylate tablet |
| 02/07/2013 | WO2013016754A1 Method and formulation for inhalation |
| 02/07/2013 | WO2012165815A3 Nano-vehicle derived from tumor tissue, and cancer vaccine using same |
| 02/07/2013 | WO2012164575A3 Amorphous ritonavir co-precipitated |
| 02/07/2013 | WO2012156997A3 Multi-particulate pharmaceutical composition |
| 02/07/2013 | WO2012138379A3 Multifunctional chelator-free radioactive nanoparticles for imaging and therapy |
| 02/07/2013 | WO2012016699A8 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4,9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 02/07/2013 | WO2012009778A3 A stable topical composition and a process for producing a stable topical composition |
| 02/07/2013 | WO2011119289A3 A process for producing a melt-extruded film, and melt-extruded film |
| 02/07/2013 | WO2005051352A8 Veterinary compositions for treating mastitis |
| 02/07/2013 | US20130035754 Drug-delivery endovascular stent and method of forming the same |
| 02/07/2013 | US20130035669 Sustained delivery of an active agent using an implantable system |
| 02/07/2013 | US20130035632 Decomposable Apparatus and Methods for Fabricating Same |
| 02/07/2013 | US20130035355 Prasugrel in micronized, crystalline form and pharmaceutical composition thereof |
| 02/07/2013 | US20130034612 Dermatological compositions comprising avermectin nanocapsules |
| 02/07/2013 | US20130034611 Sustained preparation of factor ix |
| 02/07/2013 | US20130034610 Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells |
| 02/07/2013 | US20130034609 Smart polymers functionalized hollow silica vesicles |
| 02/07/2013 | US20130034608 Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents |
| 02/07/2013 | US20130034607 Tablet |
| 02/07/2013 | US20130034606 Immediate release tablet formulations |
| 02/07/2013 | US20130034605 Extended release pharmaceutical compositions containing paliperidone |
| 02/07/2013 | US20130034604 Extended release formulations of desvenlafaxine base |
| 02/07/2013 | US20130034603 Process for preparing pharmaceutical compositions of fingolimod |
| 02/07/2013 | US20130034602 Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery |
| 02/07/2013 | US20130034601 Method for increasing lactose tolerance in mammals exhibiting lactose intolerance |
| 02/07/2013 | US20130034600 Peptide pharmaceutical of oral delivery |
| 02/07/2013 | US20130034599 Synthetic nanostructures including nucleic acids and/or other entities |
| 02/07/2013 | US20130034598 Inhibitors of akt/pkb with anti-tumor activity |
| 02/07/2013 | US20130034597 Orally bioavailable peptide drug compositions and methods thereof |
| 02/07/2013 | US20130034595 Local administration of gallium compositions to treat pain |
| 02/07/2013 | US20130034593 Method for Making Medical Devices Having Antimicrobial Coatings Thereon |